The Week in Review: September 15 – September 22, 2017

Friday, September 22, 2017 News Recap: Access to Treatment: This was a good week in terms of treatment access (but not, unfortunately, in terms of weather or seismic activity: How very, very sad).  Imagine being sick or on treatment in one of these stricken areas! In Canada Epclusa was approved for use in persons co-infected with HIV. This is very good news. Gilead Receives Approval in Canada for Expanded Indication of EPCLUSA® (Sofosbuvir/Velpat...

The Week in Review: September 8 – September 15, 2017

Friday, September 15, 2017 News Recap: President’s Report from HepCBC’s Annual General Meeting (AGM) HepCBC held its Annual General Meeting on September 12, 2017, and we are pleased to note that all the issues that we needed to address were covered.  Rosemary Plummer has stepped down as president after 2 GREAT YEARS of service, but the rest of the Board of Directors has been re-elected, and some very important changes to our Constitution and Bylaws ...

Weekly Bull August 2017

The Week in Review: August 25, 2017 – September 1, 2017 Friday, September-1-17 News Recap Not much in the news this last week, unless you take into consideration all the major tragedies that are unfolding:  Flooding in Texas, in Ontario, in India; forest fires in BC and Manitoba. How terrible. Some good information on liver cancer, however. Read more…http://hepcbc.ca/2017/09/01/week-review-august-25-september-1-2017/ The Week in Review: August...

The Week in Review: September 1 – September 8, 2017

Friday, September 8, 2017 News Recap: She thought her mystery ailment was cancer, but bloodwork revealed a surprise This is an amazing story ...but it could happen to anyone, and we know this because we hear these kinds of stories often. This is why it is so important that Boomers be tested for hepatitis C. Gail Wells got really sick and nobody could figure out why. They looked for cancer, for multiple sclerosis, for vitamin deficiencies, and then s...

The Week in Review: August 25 – September 1, 2017

Friday, September 1, 2017 News Recap: Not much in the news this last week, unless you take into consideration all the major tragedies that are unfolding:  Flooding in Texas, in Ontario, in India; forest fires in BC and Manitoba.  Imagine for a moment that you are chronically ill or elderly or both and need to have your medicines refrigerated or you need to have home care or you need dialysis.  Oh my God!!  How terrible.  No power, contaminated water,...

The Week in Review: August 18 – August 25, 2017

Friday, August 25, 2017 News Recap: Public health issues Hep B risk warning: Tools used in procedures such as callus scraping and cutting toenails could become contaminated with the virus and remain contaminated because of the sterilization practices followed. Public health authorities in Owen Sound have identified a local foot care clinic as a potential source of hepatitis B and are warning patients – other than orthotics patients – to consult a doc...

The Week in Review: August 11 – August 18, 2017

Friday, August 18, 2017 Canada Great news in Canada. Two new drug regimens have been approved:  Vosevi from Gilead is a pangenotypic for retreatment of those who have failed previous DAA therapy Gilead Receives Approval in Canada for VOSEVI™ (Sofosbuvir/Velpatasvir/Voxilaprevir) for Re-treatment of Certain Patients with Chronic Hepatitis C Virus (HCV) Infection. And MAVIRET from AbbVie is the first and only 8-week, pan-genotypic treatment for hepatit...

The Week in Review: August 4 – August 11, 2017

Friday, August 11, 2017 Research & Discoveries Melbourne scientists are creating mini-livers in a dish MELBOURNE scientists are creating mini livers in a dish using a world-first combination of human cells in an ambitious bid to grow liver tissue for transplants. The tiny experimental organs – developed from cells donated by cancer patients – will be used to test drugs and eventually treat disease. Routine hospital tool found to predict poor ...

The Week in Review: July 28 – August 4, 2017

Friday, August 4, 2017 Treatment: This last week saw the approval in the U.S. of AbbVie’s Mavyret, a pangenotypic also indicated as recuperation therapy for those with GT1 who have failed treatment with DAAs. U.S.: FDA approves Mavyret for Hepatitis C As well, the FDA has approved updated labeling for Epclusa to include use in patients co-infected with HIV. U.S. FDA Approves Expanded Labeling for Epclusa® (Sofosbuvir/Velpatasvir) for the Treatmen...

The Week in Review: July 21 – July 28, 2017

Friday, July 28, 2017 News Recap WHD 2017 Victoria, BC in Pictures The weather was perfect; the organization and volunteers did great!!!!  The speakers were fabulous!! I only wish more people had shown up!!!  Big thanks to VPWAS and AVI for helping to make this important event a reality! Click on photos to see larger image in a new window! Should we be worried about hepatitis E? Hepatitis E virus infection (HEV) is the most common cause of a...